Xingyi Xie

Fluorocarbon chain end-capped poly(carbonate urethane)s as biomaterials: blood compatibility and chemical stability assessments.

Previous work has shown the synthesis of fluorocarbon chain (CF(3)(CF(2))(6)CH(2)O-) end-capped poly(carbonate urethane)s (FPCUs) and confirmed the presence of a novel bilayered surface structure in FPCUs, that is, the top fluorocarbon and subsurface hard segment layers (Xie et al., J Biomed Mater Res Part A 2008; 84:30-43). In this work, the effects of such surface structure on blood compatibility were investigated using hemolytic test and platelet adhesion analysis. The chemical stability of the polymers was also determined by Zhaos glass wool-H(2)O(2)/CoCl(2) test and phosphate-buffered saline (PBS, pH = 3.1-3.3) treatment. One of the FPCUs, FPCU-A, and two control materials, a poly(ether urethane) (PEU) and a poly(carbonate urethane) (PCU), were investigated. No significant difference in hemolytic indices was observed among the three materials, whereas the adherent density and deformation of platelets were much lower on FPCU-A compared with on PCU and PEU. Severe surface cracking and surface buckling developed in prestressed PEU and PCU films after H(2)O(2)/CoCl(2) treatment, respectively, whereas smooth surface was observed for the FPCU-A. PBS incubation resulted in parallel ridge-like morphology in PCU whereas PEU and FPCU-A retained their smooth surfaces. Under relatively high stress conditions, all the materials developed well-oriented strip-like surface patterns. Results from ATR-FTIR spectra revealed a surface oxidation mechanism as described in literature. However, observations of universal decrease of molecular weights under stress conditions further suggested the presence of another bulk stress oxidation mechanism. Regardless the degradation mechanisms involved, the unique bilayered surface structure really improved the blood compatibility and chemical stability of FPCU-A, indicating that further in vivo investigations are worthwhile.

Fluoropassivation and gelatin sealing of polyester arterial prostheses to skip preclotting and constrain the chronic inflammatory response.

Fluoropassivation and gelatin coating have been applied to polyethylene terephthalate (PET) vascular prosthesis to combine the advantages of both polytetrafluoroethylene (PTFE) and PET materials, and to eliminate the preclotting procedure. The morphological, chemical, physical, and mechanical properties of such prostheses were investigated and compared with its original model. Fluoropassivation introduced -OCF(3), -CF(3), and -CFCF(2)- structures onto the surface of the polyester fibers. However, the surface fluorine content was only 28-32% compared to the 66% in expanded PTFE (ePTFE) grafts. The fluoropassivation decreased the hydrophilicity, slightly increased the water permeability, and marginally lowered the melting point and the crystallinity of the PET fibers. After gelatin coating, the fluoropassivated and nonfluoropassivated prostheses showed similar surface morphology and chemistry. While gelatin coating eliminated preclotting, it also renders the prostheses slightly stiffer. The original prosthesis had the highest bursting strength (275 N), with the fluoropassivated and gelatin-sealed devices showing similar bursting strength between 210 and 230 N. Fluoropassivation and gelatin coating lowered the retention strength by 23 and 30% on average, respectively. In vitro enzymatic incubation had only marginal effect on the surface fluorine content of the nongelatin-sealed prostheses. However, the gelatin-sealed ones significantly lost their surface fluorine after in vitro enzymatic incubation (by 69-85%) or in vivo 6-month implantation (by 51-60%), showing the lability of the fluoropolymer layer under the hostile biological environment.

Prenatal developmental safety of functional polyurethanes for cardiovascular implants

Historically, polyurethanes have been regarded as promising materials for cardiovascular implants such as vascular grafts and heart valves. Their biocompatibility has been thoroughly investigated. However, their developmental toxicity is seldom reported. We recently developed two polycarbonate urethanes with polyethylene glycol side chains capped with epoxy or amino groups that can further react with specific biomolecules. Both materials in microfibrillar morphology were subjected to saline extraction at 70 °C to prompt material hydrolysis. Proton nuclear magnetic resonance, Fourier transform infrared spectroscopy, and gel permeation chromatography all confirmed the degradation of the polyurethanes. The saline extracts containing the degradation products were administered to Sprague-Dawley female rats on day 7 to 16 of gestation via tail vein injection at a dose of 5 mL/kg/day. No maternal toxicity was observed. No external, skeletal, and visceral malformations in fetuses were found associated with the test materials, implying their safety to both adult rats and the offspring. Further investigations for applications in vascular grafts are under way.

Toward endothelialization via vascular endothelial growth factor immobilization on cell-repelling functional polyurethanes: Endothelialization Via Vascular Endothelial Growth Factor

We screened a family of nonspecific cell-repelling polyurethanes (PUs) whose backbones are attached with epoxy group-terminated polyethylene glycol (PEG) side chains. Water incubation of the PU films (with 9.2-31.1 wt % PEG) caused a surface enrichment of PEG chains where vascular endothelial growth factor (VEGF) was grafted by forming secondary amine linkages between VEGF molecules and the PEG spacer. These linkages are still ionizable similar to original primary amines in VEGF, thereby retaining the original charge distribution on VEGF macromolecules. This charge conservation together with PEG steric repulsion helped to preserve VEGF conformation and bioactivity. The PU substrates with suitable hard segments contents and VEGF surface densities can selectively induce endothelial cells (ECs) adhesion and proliferation toward endothelialization. Moreover, the PU substrates, even grafted with fibrinogen (Fg), cannot trigger platelet adhesion and deformation, suggesting an inactive conformation of the grafted Fg. Thus enough antithrombogenicity of the PU substrates could be expected before full endothelialization. These PU materials might be applied onto the lumens of vascular grafts, potentially stimulating luminal endothelialization in vivo.